|

Zinc Acexamate Clinical Trials

1 actively recruiting trial

Also known as: Placebo

Pipeline

Phase 3: 1

Top Sponsors

  • Hospital Universitari Vall d'Hebron Research Institute1

Indications

  • Liver Disease1
  • Portal Hypertension1
  • Advanced Chronic Liver Disease1
  • Liver Cancer1
  • Hepatocellular Carcinoma1

Other1 trial

Zinc Supplementation to Improve Prognosis in Patients With Compensated Advanced Chronic Liver Disease.
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.